Evidence map›Paper›PMID 26034547›Full record

ArticleJundishapur journal of microbiology2015

Metallo-beta-Lactamase VIM-1, SPM-1, and IMP-1 Genes Among Clinical Pseudomonas aeruginosa Species Isolated in Zahedan, Iran.

Mehdi Ghamgosha, Shahram Shahrekizahedani, Farshid Kafilzadeh, Zakaria Bameri, Ramezan Ali Taheri, Gholamreza Farnoosh

Open access · hybridAbstract read
In one paragraph

Article in Jundishapur journal of microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Phenotypic and genotypic investigation of metallo-β-lactamases inIranian journal of basic medical sciences · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mehdi GhamgoshaNeurosciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Shahram ShahrekizahedaniDepartment of Medical Microbiology, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Farshid KafilzadehDepartment of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, IR Iran.
Zakaria BameriInfectious Disease and Tropical Medical Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran.
Ramezan Ali TaheriNanobiotechnology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Gholamreza FarnooshApplied Biotechnology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Baqiyatallah University of Medical Sciences · IRZahedan University of Medical Sciences · IRIslamic Azad University, Jahrom Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the major clinical problems regarding Pseudomonas aeruginosa is attributed to metallo-beta-lactamases (MBL). This group of enzymes is a subset of beta lactamases which belong to group B of Ambler classification and cause hydrolysis of carbapenems. Based on epidemiological studies conducted worldwide, it is proved that prevalence of genes coding MBLs in P. aeruginosa species are different in various geographic zones and even in various hospitals. Therefore, according to the clinical importance of organisms generating MBLs, it is necessary to identify and control these bacteria in hospitals for therapeutic purposes.

objectivesThe current study aimed to investigate the Metallo-beta-Lactamase VIM-1, SPM-1, and IMP-1 genes among clinical P. aeruginosa species isolated in Zahedan, Iran. MATERIALS AND

methodsThe current study investigated the presence of MBL through phenotypic and genotypic methods and also the pattern of antibiotic resistance in P. aeruginosa species isolated in hospitals. The Minimum Inhibitory Concentration (MIC) against imipeneme was measured for 191 P. aeruginosa species isolated from Zahedan hospitals after identification through biochemical methods and determination of the antibiotic resistance pattern. Strains with MIC > 4 µg/mL were studied by phenotypic and genotypic methods.

resultsThe rate of resistance against imipeneme was 5.7% and after carrying out the phenotypic experiments, nine species were identified as of MBL producer. Seven species were confirmed by Polymerase Chain Reaction (PCR) method. Gene VIM-1 was the predominant gene among the positive (antibiotic resistant) species.

conclusionsThe study results showed that MBL genes were present in some of the species isolated from Zahedan hospitals. Regarding the importance of MBL producer bacteria in hospitals, quick identification and evaluation of these clinical species can be considered as an important and basic step for treatment and control of pseudomonad infections.

Indexed as

Antibiotic ResistanceImipenemeMetallo-beta-lactamasePseudomonas aeruginosa

Identifiers

PMID26034547
PMCPMC4449845
OpenAlexW2137073504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.